32 related articles for article (PubMed ID: 2691957)
1. Genetics of melanoma.
Wangari-Talbot J; Chen S
Front Genet; 2012; 3():330. PubMed ID: 23372575
[TBL] [Abstract][Full Text] [Related]
2. Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatment.
Anvekar RA; Asciolla JJ; Missert DJ; Chipuk JE
Front Oncol; 2011 Oct; 1(34):. PubMed ID: 22268005
[TBL] [Abstract][Full Text] [Related]
3. Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.
Drescher KM; Sharma P; Lynch HT
Clin Dev Immunol; 2010; 2010():170432. PubMed ID: 20631828
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.
VanBrocklin MW; Robinson JP; Lastwika KJ; Khoury JD; Holmen SL
Pigment Cell Melanoma Res; 2010 Aug; 23(4):531-41. PubMed ID: 20444198
[TBL] [Abstract][Full Text] [Related]
5. Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.
Platz A; Egyhazi S; Ringborg U; Hansson J
Mol Oncol; 2008 Apr; 1(4):395-405. PubMed ID: 19383313
[TBL] [Abstract][Full Text] [Related]
6. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.
Brewer JK
J Mol Neurosci; 2008 Jul; 35(3):307-22. PubMed ID: 18563304
[TBL] [Abstract][Full Text] [Related]
7. Molecular aspects of melanocytic dysplastic nevi.
Hussein MR; Wood GS
J Mol Diagn; 2002 May; 4(2):71-80. PubMed ID: 11986397
[TBL] [Abstract][Full Text] [Related]
8. Novel Ras antagonist blocks human melanoma growth.
Jansen B; Schlagbauer-Wadl H; Kahr H; Heere-Ress E; Mayer BX; Eichler H; Pehamberger H; Gana-Weisz M; Ben-David E; Kloog Y; Wolff K
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14019-24. PubMed ID: 10570191
[TBL] [Abstract][Full Text] [Related]
9. msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation.
Shioda T; Fenner MH; Isselbacher KJ
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12298-303. PubMed ID: 8901575
[TBL] [Abstract][Full Text] [Related]
10. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI
Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392
[TBL] [Abstract][Full Text] [Related]
11. Activated ras. Yet another player in melanoma?
Herlyn M; Satyamoorthy K
Am J Pathol; 1996 Sep; 149(3):739-44. PubMed ID: 8780377
[No Abstract] [Full Text] [Related]
12. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras.
Johnson MR; Look AT; DeClue JE; Valentine MB; Lowy DR
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5539-43. PubMed ID: 8516298
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin.
Yamamoto M; Takahashi H
Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):127-32. PubMed ID: 8465513
[TBL] [Abstract][Full Text] [Related]
14. Growth factor independence and growth regulatory pathways in human melanoma development.
Rodeck U
Cancer Metastasis Rev; 1993 Sep; 12(3-4):219-26. PubMed ID: 8281609
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma.
Jafari M; Papp T; Kirchner S; Diener U; Henschler D; Burg G; Schiffmann D
J Cancer Res Clin Oncol; 1995; 121(1):23-30. PubMed ID: 7860615
[TBL] [Abstract][Full Text] [Related]
16. No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited.
Mooy CM; Van der Helm MJ; Van der Kwast TH; De Jong PT; Ruiter DJ; Zwarthoff EC
Br J Cancer; 1991 Aug; 64(2):411-3. PubMed ID: 1892776
[No Abstract] [Full Text] [Related]
17. ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development.
Shukla VK; Hughes DC; Hughes LE; McCormick F; Padua RA
Oncogene Res; 1989; 5(2):121-7. PubMed ID: 2691957
[TBL] [Abstract][Full Text] [Related]
18. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
[TBL] [Abstract][Full Text] [Related]
19. Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.
Omholt K; Karsberg S; Platz A; Kanter L; Ringborg U; Hansson J
Clin Cancer Res; 2002 Nov; 8(11):3468-74. PubMed ID: 12429636
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
